Ledipasvir Products | Cleanchem - Latanoprost is a prostaglandin analog used as an ophthalmic solution to treat elevated intraocular pressure in conditions like glaucoma and ocular hypertension. It increases the outflow of aqueous humor through the uveoscleral pathway, reducing eye pressure. It is applied once daily at bedtime and may cause side effects such as eye redness, pigmentation of the iris, and eyelash growth.

Ledipasvir

Cat. No: CL-LDP-01

CAS No: NA

Mol. F: NA

Mol. Wt: NA

Inv. Status: Custom Synthesis

Ledipasvir Diastereomer-1

Cat. No: CL-LDP-02

CAS No: NA

Mol. F: C49H54F2N8O6

Mol. Wt: 889

Inv. Status: Custom Synthesis

Ledipasvir Diastereomer-2

Cat. No: CL-LDP-03

CAS No: 1256391-66-8

Mol. F: C49H54F2N8O6

Mol. Wt: 889

Inv. Status: Custom Synthesis

Ledipasvir D-Valine-Disteromer

Cat. No: CL-LDP-04

CAS No: NA

Mol. F: C49H54F2N8O6

Mol. Wt: 889

Inv. Status: Custom Synthesis

Ledipasvir Keto Impurity-1

Cat. No: CL-LDP-05

CAS No: NA

Mol. F: C29H29BrN4O4

Mol. Wt: 577.5

Inv. Status: Custom Synthesis

Ledipasvir Keto Impurity-2

Cat. No: CL-LDP-06

CAS No: 2040487-43-0

Mol. F: C49H54N8O7

Mol. Wt: 867

Inv. Status: Custom Synthesis

Ledipasvir 1R-Diastereomer

Cat. No: CL-LDP-07

CAS No: NA

Mol. F: C49H54F2N8O6

Mol. Wt: 889

Inv. Status: Custom Synthesis

Ledipasvir Impurity-3

Cat. No: CL-LDP-10

CAS No: 1256388-50-7

Mol. F: C29H29BrF2N4O3

Mol. Wt: 599.5

Inv. Status: Custom Synthesis

Ledipasvir Impurity-4

Cat. No: CL-LDP-11

CAS No: NA

Mol. F: C29H29BrF2N4O3

Mol. Wt: 599.4

Inv. Status: Custom Synthesis

Ledipasvir Impurity-5

Cat. No: CL-LDP-12

CAS No: NA

Mol. F: C49H54F2N8O6

Mol. Wt: 889

Inv. Status: Custom Synthesis

Ledipasvir Impurity-6

Cat. No: CL-LDP-13

CAS No: NA

Mol. F: C29H29BrF2N4O3

Mol. Wt: 599.5

Inv. Status: Custom Synthesis

Ledipasvir 1S,3R,4R-Diastereomer

Cat. No: CL-LDP-14

CAS No: NA

Mol. F: C49H54F2N8O6

Mol. Wt: 889

Inv. Status: Custom Synthesis

Ledipasvir 1S,3R,4S-Diastereomer

Cat. No: CL-LDP-15

CAS No: NA

Mol. F: C49H54F2N8O6

Mol. Wt: 889

Inv. Status: Custom Synthesis

Ledipasvir 1R,3S,4R Diastereomer

Cat. No: CL-LDP-16

CAS No: NA

Mol. F: C49H54F2N8O6

Mol. Wt: 889

Inv. Status: Custom Synthesis

Ledipasvir Impurity-7

Cat. No: CL-LDP-17

CAS No: NA

Mol. F: C18H23N3O2

Mol. Wt: 313.4

Inv. Status: Custom Synthesis

Ledipasvir Impurity-8

Cat. No: CL-LDP-18

CAS No: NA

Mol. F: C18H23N3O2

Mol. Wt: 313.4

Inv. Status: Custom Synthesis

Ledipasvir Impurity-9

Cat. No: CL-LDP-19

CAS No: NA

Mol. F: C18H23N3O2

Mol. Wt: 313.4

Inv. Status: Custom Synthesis

Ledipasvir Impurity-10

Cat. No: CL-LDP-20

CAS No: NA

Mol. F: C18H23N3O2

Mol. Wt: 313.4

Inv. Status: Custom Synthesis

Ledipasvir Impurity-11

Cat. No: CL-LDP-21

CAS No: 1256387-87-7

Mol. F: C24H34BN3O4

Mol. Wt: 439.4

Inv. Status: Custom Synthesis

Ledipasvir Impurity-12

Cat. No: CL-LDP-22

CAS No: NA

Mol. F: C24H34BN3O4

Mol. Wt: 439.4

Inv. Status: Custom Synthesis

Ledipasvir Impurity-13

Cat. No: CL-LDP-23

CAS No: NA

Mol. F: C24H34BN3O4

Mol. Wt: 439.4

Inv. Status: Custom Synthesis

Ledipasvir Impurity-14

Cat. No: CL-LDP-24

CAS No: NA

Mol. F: C24H34BN3O4

Mol. Wt: 439.4

Inv. Status: Custom Synthesis

Ledipasvir Impurity-15

Cat. No: CL-LDP-25

CAS No: 1378387-87-1

Mol. F: C26H37BN4O5

Mol. Wt: 496.4

Inv. Status: Custom Synthesis

Ledipasvir Impurity-16

Cat. No: CL-LDP-26

CAS No: NA

Mol. F: C26H37BN4O5

Mol. Wt: 496.4

Inv. Status: Custom Synthesis

Ledipasvir Impurity-17

Cat. No: CL-LDP-27

CAS No: NA

Mol. F: C26H37BN4O5

Mol. Wt: 496.4

Inv. Status: Custom Synthesis

Ledipasvir Impurity-18

Cat. No: CL-LDP-28

CAS No: NA

Mol. F: C26H37BN4O5

Mol. Wt: 496.4

Inv. Status: Custom Synthesis

Ledipasvir Impurity-19

Cat. No: CL-LDP-29

CAS No: 1129634-44-1

Mol. F: C12H19NO4

Mol. Wt: 241.3

Inv. Status: Custom Synthesis

Ledipasvir Intermediate 2

Cat. No: CL-LDP-31

CAS No: 1441670-89-8

Mol. F: C27H26BrF2N3O2

Mol. Wt: 542.4

Inv. Status: Custom Synthesis

Ledipasvir-d6

Cat. No: CL-LDP-32

CAS No: NA

Mol. F: C49H48D6F2N8O6

Mol. Wt: 895.1

Inv. Status: Custom Synthesis

Ledipasvir-M9 Metabolite

Cat. No: CL-LDP-33

CAS No: NA

Mol. F: C47H52F2N8O4

Mol. Wt: 831

Inv. Status: Custom Synthesis

1-epi-Ledipasvir

Cat. No: CL-LDP-34

CAS No: 1256393-35-7

Mol. F: C49H54F2N8O6

Mol. Wt: 889

Inv. Status: Custom Synthesis

Ledipasvir Intermediate 1

Cat. No: CL-LDP-35

CAS No: 291775-59-2

Mol. F: C12H19NO4

Mol. Wt: 241.3

Inv. Status: Custom Synthesis

Ledipasvir Acetyl Spiro Impurity

Cat. No: CL-LDP-36

CAS No: 2040487-36-1

Mol. F: C44H45F2N7O4

Mol. Wt: 773.9

Inv. Status: Custom Synthesis

Ledipasvir Impurity 20

Cat. No: CL-LDP-37

CAS No: 1256393-27-7

Mol. F: C47H51F2N7O5

Mol. Wt: 832

Inv. Status: Custom Synthesis

Ledipasvir Impurity 21

Cat. No: CL-LDP-38

CAS No: 1499193-67-7

Mol. F: C35H32F2N6 : 4(HCl)

Mol. Wt: 574.7 : 4(36.5)

Inv. Status: Custom Synthesis

Ledipasvir D-Tartrate

Cat. No: CL-LDP-39

CAS No: 1499193-68-8

Mol. F: C49H54F2N8O6 : C4H6O6

Mol. Wt: 889.0 : 150.1

Inv. Status: Custom Synthesis